FDA Clearance Tracker · P190031-S016
VENTANA HER2 Dual ISH DNA Probe Cocktail
Last checked: Nov 20, 2026Latest source record: Aug 25, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Aug 25, 2026
Approved
Time to decision
153 days
Received Mar 25, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class II
The decision
- FDA number
- P190031-S016
- Device name
- VENTANA HER2 Dual ISH DNA Probe Cocktail
- Applicant
- Ventana Medical Systems, Inc.
- Applicant location
- Tucson, AZ
- Received
- Mar 25, 2026
- Decided
- Aug 25, 2026
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P190031
Device type
- Device type
- Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer (NYQ)
- Device class
- Class II
- Regulation
- 21 CFR 864.1890
- Specialty
- Laboratory Medicine & Pathology
FDA's approval statement
As written in FDA's record.
Approval of VENTANA HER2 Dual ISH DNA Probe Cocktail to add the indication for use as a companion diagnostic (CDx) for identifying patients with gastroesophageal adenocarcinoma (GEA; gastric, gastroesophageal junction and esophageal adenocarcinoma) who many benefit from treatment with ZIIHERA (zanidatamab).
Source documents
Other decisions for Ventana Medical Systems, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P990081-S060 · Decided Aug 25, 2026 · 153 days after receipt · Panel Track
Device type: SYSTEM, TEST, HER-2/NEU, IHC (MVC) · Laboratory Medicine & Pathology
P250031 · Decided Jun 12, 2026 · 298 days after receipt
Device type: Immunohistochemistry Assay, Antibody (SHF) · Laboratory Medicine & Pathology
P240037 · Decided May 14, 2025 · 205 days after receipt
Device type: Immunohistochemistry Assay, Antibody, MET (SER) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.